Cargando…
Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses
Metformin is a glucose‐lowering drug commonly found in municipal wastewater effluents (MWWEs). The present study investigated the chronic effects of metformin in early‐life stages of the fathead minnow (Pimephales promelas). Endpoints assessed were growth, survival, and deformities. The larval gut m...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291798/ https://www.ncbi.nlm.nih.gov/pubmed/33788292 http://dx.doi.org/10.1002/etc.5054 |
_version_ | 1784749216148488192 |
---|---|
author | Parrott, Joanne L. Restivo, Victoria E. Kidd, Karen A. Zhu, Juliet Shires, Kallie Clarence, Stacey Khan, Hufsa Sullivan, Cheryl Pacepavicius, Grazina Alaee, Mehran |
author_facet | Parrott, Joanne L. Restivo, Victoria E. Kidd, Karen A. Zhu, Juliet Shires, Kallie Clarence, Stacey Khan, Hufsa Sullivan, Cheryl Pacepavicius, Grazina Alaee, Mehran |
author_sort | Parrott, Joanne L. |
collection | PubMed |
description | Metformin is a glucose‐lowering drug commonly found in municipal wastewater effluents (MWWEs). The present study investigated the chronic effects of metformin in early‐life stages of the fathead minnow (Pimephales promelas). Endpoints assessed were growth, survival, and deformities. The larval gut microbiome was also examined using 16 S ribosomal RNA gene amplicon sequencing to determine microbial community composition and alpha and beta diversity. Eggs and larvae were exposed to metformin measured concentrations (mean [standard deviation]) of 0.020 (0.017) μg/L (for controls) and 3.44 (0.23), 33.6 (1.6), and 269 (11) μg/L in a daily static‐renewal setup, with 20 embryos per beaker. The low and middle metformin exposure concentrations represent river and MWWE concentrations of metformin. To detect small changes in growth, we used 18 replicate beakers for controls and 9 replicates for each metformin treatment. Over the 21‐d exposure (5 d as embryos and 16 d posthatch [dph]), metformin did not affect survival or growth of larval fish. Hatch success, time to hatch, deformities in hatched fry, and survival were similar across all treatments. Growth (wet wt, length, and condition factor) assessed at 9 and 16 dph was also unaffected by metformin. Assessment of the microbiome showed that the larvae microbiome was dominant in Proteobacteria and Firmicutes, with small increases in Proteobacteria and decreases in Firmicutes with increasing exposure to metformin. No treatment effects were found for microbiome diversity measures. Control fish euthanized with the anesthetic tricaine methane sulfonate had decreased alpha diversity compared to those sampled by spinal severance. This experiment demonstrates that metformin at environmentally relevant concentrations (3.44 and 33.6 μg/L) and at 10 times MWWE concentrations (269 µg/L) does not adversely affect larval growth or gut microbiome in this ubiquitous freshwater fish species. Environ Toxicol Chem 2022;41:635–647. © 2021 Her Majesty the Queen in Right of Canada. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC. Reproduced with the permission of the Minister of Environment and Climate Change Canada. |
format | Online Article Text |
id | pubmed-9291798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92917982022-07-20 Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses Parrott, Joanne L. Restivo, Victoria E. Kidd, Karen A. Zhu, Juliet Shires, Kallie Clarence, Stacey Khan, Hufsa Sullivan, Cheryl Pacepavicius, Grazina Alaee, Mehran Environ Toxicol Chem Special Section Metformin is a glucose‐lowering drug commonly found in municipal wastewater effluents (MWWEs). The present study investigated the chronic effects of metformin in early‐life stages of the fathead minnow (Pimephales promelas). Endpoints assessed were growth, survival, and deformities. The larval gut microbiome was also examined using 16 S ribosomal RNA gene amplicon sequencing to determine microbial community composition and alpha and beta diversity. Eggs and larvae were exposed to metformin measured concentrations (mean [standard deviation]) of 0.020 (0.017) μg/L (for controls) and 3.44 (0.23), 33.6 (1.6), and 269 (11) μg/L in a daily static‐renewal setup, with 20 embryos per beaker. The low and middle metformin exposure concentrations represent river and MWWE concentrations of metformin. To detect small changes in growth, we used 18 replicate beakers for controls and 9 replicates for each metformin treatment. Over the 21‐d exposure (5 d as embryos and 16 d posthatch [dph]), metformin did not affect survival or growth of larval fish. Hatch success, time to hatch, deformities in hatched fry, and survival were similar across all treatments. Growth (wet wt, length, and condition factor) assessed at 9 and 16 dph was also unaffected by metformin. Assessment of the microbiome showed that the larvae microbiome was dominant in Proteobacteria and Firmicutes, with small increases in Proteobacteria and decreases in Firmicutes with increasing exposure to metformin. No treatment effects were found for microbiome diversity measures. Control fish euthanized with the anesthetic tricaine methane sulfonate had decreased alpha diversity compared to those sampled by spinal severance. This experiment demonstrates that metformin at environmentally relevant concentrations (3.44 and 33.6 μg/L) and at 10 times MWWE concentrations (269 µg/L) does not adversely affect larval growth or gut microbiome in this ubiquitous freshwater fish species. Environ Toxicol Chem 2022;41:635–647. © 2021 Her Majesty the Queen in Right of Canada. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC. Reproduced with the permission of the Minister of Environment and Climate Change Canada. John Wiley and Sons Inc. 2021-06-02 2022-03 /pmc/articles/PMC9291798/ /pubmed/33788292 http://dx.doi.org/10.1002/etc.5054 Text en © 2021 Her Majesty the Queen in Right of Canada. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC. Reproduced with the permission of the Minister of Environment and Climate Change Canada. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Special Section Parrott, Joanne L. Restivo, Victoria E. Kidd, Karen A. Zhu, Juliet Shires, Kallie Clarence, Stacey Khan, Hufsa Sullivan, Cheryl Pacepavicius, Grazina Alaee, Mehran Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses |
title | Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses |
title_full | Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses |
title_fullStr | Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses |
title_full_unstemmed | Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses |
title_short | Chronic Embryo‐Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses |
title_sort | chronic embryo‐larval exposure of fathead minnows to the pharmaceutical drug metformin: survival, growth, and microbiome responses |
topic | Special Section |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291798/ https://www.ncbi.nlm.nih.gov/pubmed/33788292 http://dx.doi.org/10.1002/etc.5054 |
work_keys_str_mv | AT parrottjoannel chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses AT restivovictoriae chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses AT kiddkarena chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses AT zhujuliet chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses AT shireskallie chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses AT clarencestacey chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses AT khanhufsa chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses AT sullivancheryl chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses AT pacepaviciusgrazina chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses AT alaeemehran chronicembryolarvalexposureoffatheadminnowstothepharmaceuticaldrugmetforminsurvivalgrowthandmicrobiomeresponses |